Project Details
Projekt Print View

Molecular imaging of the alveolar echinococcosis in small animals

Applicant Dr. Stefan Wiehr
Subject Area Nuclear Medicine, Radiotherapy, Radiobiology
Medical Physics, Biomedical Technology
Term from 2011 to 2016
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 195043480
 
Final Report Year 2018

Final Report Abstract

The rapid, non-invasive and highly specific diagnosis of infectious diseases is still challenging, although novel techniques from the field of radiology and nuclear medicine have been implemented. During the funding period the development of pathogen-specific antibody-based PET tracers for the molecular imaging of the severe infectious disease, the parasitic zoonosis alveolar echinococcosis, was performed. Standard clinical PET tracers (e.g. [18F]FDG, [18F]FLT etc.) were evaluated in animal model the diseases in order to extend the diagnostic armamentarium for clinicians. However, standard PET tracers, especially [18F]FDG, revealed to lack specificity being unable to discriminate between sterile and pathogen-induced inflammation and infectious diseases as it is taken up by highly proliferating immune cells frequently infiltrating the site of infection. The E. multilocularis-specific mAb MAbG11 was radiolabeled with 64Cu for the molecular imaging of AE in immunoPET. The tracers showed excellent potential for the highly specific detection of the pathogen in vivo. [64Cu]DOTA- MAbG11 or its 89Zr-labeled variant revealed highly specific binding to E. multilocularis in vitro, and in part in vivo, whereas binding characteristics of this PET tracer need to be further improved and specificity has to be verified in additional control studies using various other pathogens. The findings presented here show the high potential of immunoPET for the rapid, non-invasive, and highly specific diagnosis of infectious diseases. The high potential for the clinical translation of the antibody-based PET tracer was confirmed as it could provide improved diagnosis and staging of the infectious disease in patients as well as beneficial effects on therapy planning and monitoring of the response to antiparasitic treatment.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung